The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Clears Eversense 365, Marking First 1-Year CGM Option in Diabetes

September 18th 2024

The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.

GLP-1 RA Linked to Lower Risk of Cirrhosis Development in Patients with MASLD
GLP-1 RA Linked to Lower Risk of Cirrhosis Development in Patients with MASLD

September 16th 2024

HCPLive Endocrinology Month In Review August 2024
Endocrinology Month in Review: August 2024

September 10th 2024

Semaglutide Reduces Rates of Cardiovascular, COVID-19-Related Deaths
Semaglutide Reduces Rates of Cardiovascular, COVID-19-Related Deaths

September 7th 2024

Brian Callaghan, MD, MS | Credit: Michigan Medicine
Study Finds Diabetes Complications and Mental Health Disorders Are a 2-Way Street

August 27th 2024

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities
© 2024 MJH Life Sciences

All rights reserved.